Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    Search Startups

    Tagged as ('immunotherapy') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    42 Startups 8 In the News 9 Recently Updated
    • Total Funding
      $1.13B
      Raised
      80
      Events
    • Private Funding
      $649.83M
      Raised
      41
      Rounds
    • Public Offerings
      $480.35M
      Raised
      39
      Offerings
    • M&A
      $0
      Raised
      0
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    CytoReason logo

    CytoReason

    Machine Learning for Data-driven Target Discovery and Drug Development
    2016 B2B 51-200 A $52M
    laboratories
    artificial-intelligence
    healthcare-providers
    patent-pending
    drug-discovery
    clinical-data
    clinics
    medical-technologies
    data-analytics
    digital-healthcare
    big-data
    pharma-companies
    cancer
    machine-learning
    biotechnology
    biopharmaceutical
    immunotherapy
    immunology
    bioinformatics
    mhealth
    autoimmune-diseases
    molecular-biology
    decision-support
    natural-language-processing
    cells
    Nucleai logo

    Nucleai

    AI-powered Image Analysis for Precision Medicine
    2017 B2B 51-200 B $60.5M
    bioconvergence
    healthcare-providers
    machine-learning
    diagnostics
    oncology
    cancer
    digital-healthcare
    deep-learning
    artificial-intelligence
    computer-vision
    precision-medicine
    medical-technologies
    hospitals
    imaging
    biomarkers
    software-platform
    cloud-based
    laboratories
    decision-support
    pharmaceuticals
    pharma-companies
    immunotherapy
    Immunai logo

    Immunai

    Peripheral Tissue Analysis
    2019 B2B 51-200 B $295M
    immunotherapy
    unicorn-2021
    digital-healthcare
    hospitals
    immunology
    data-analytics
    actionable-insights
    pharma-companies
    cancer
    autoimmune-diseases
    artificial-intelligence
    machine-learning
    deep-learning
    cells
    Pangea Biomed logo

    Pangea Biomed

    Pan-cancer Therapy Response Predictor
    2018 B2B 11-50 Seed $12M
    actionable-insights
    biotechnology
    precision-medicine
    treatments
    oncology
    artificial-intelligence
    targeted-therapy
    pharma-companies
    digital-healthcare
    decision-support
    machine-learning
    immunotherapy
    cancer
    drug-discovery
    laboratories
    personalization
    Canopy Immuno-Therapeutics logo

    Canopy Immuno-Therapeutics

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunotherapeutic Approach for Autoimmunity and Life-threatening Allergies
    2020 B2B 1-10 Seed Undisclosed
    biotechnology
    inflammatory-diseases
    allergy
    treatments
    artificial-intelligence
    software-platform
    life-sciences
    immunology
    immuno-theraphy
    drug-development
    immunotherapy
    NanoGhost logo

    NanoGhost

    Naturally Targeted Drug-delivery System
    2019 B2B 11-50 Seed $9M
    cancer
    targeted-therapy
    stem-cells
    drug-delivery
    nanotechnology
    immunotherapy
    treatments
    pharmaceuticals
    biotechnology
    genetics
    Atox Bio logo

    Atox Bio

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    2003 B2B 11-50 F $64.85M
    inflammatory-diseases
    infectious-disease
    ischemia
    immunology
    orphan-drug
    therapeutics
    critical-care
    pharmaceuticals
    immunotherapy
    patients
    biotechnology
    healthcare-providers

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    42 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $1.13B
      Raised
      80
      Events
    • Private Funding
      $649.83M
      Raised
      41
      Rounds
    • Public Offerings
      $480.35M
      Raised
      39
      Offerings
    • M&A
      $0
      Raised
      0
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    CytoReason logo
    Raised
    $52M
    CytoReason
    Machine Learning for Data-driven Target Discovery and Drug Development
    Founded:2016
    Business Model:B2B
    Employees:51-200
    Funding Stage:A
    Nucleai logo
    Raised
    $60.5M
    Nucleai
    AI-powered Image Analysis for Precision Medicine
    Founded:2017
    Business Model:B2B
    Employees:51-200
    Funding Stage:B
    Immunai logo
    Raised
    $295M
    Immunai
    Peripheral Tissue Analysis
    Founded:2019
    Business Model:B2B
    Employees:51-200
    Funding Stage:B
    Pangea Biomed logo
    Raised
    $12M
    Pangea Biomed
    Pan-cancer Therapy Response Predictor
    Founded:2018
    Business Model:B2B
    Employees:11-50
    Funding Stage:Seed
    Canopy Immuno-Therapeutics logo
    Raised
    Undisclosed
    Canopy Immuno-Therapeutics
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunotherapeutic Approach for Autoimmunity and Life-threatening Allergies
    Founded:2020
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    NanoGhost logo
    Raised
    $9M
    NanoGhost
    Naturally Targeted Drug-delivery System
    Founded:2019
    Business Model:B2B
    Employees:11-50
    Funding Stage:Seed
    Atox Bio logo
    Raised
    $64.85M
    Atox Bio
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    Founded:2003
    Business Model:B2B
    Employees:11-50
    Funding Stage:F
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,